The University of Queensland will play a key role in a national effort to revolutionize treatment for men with prostate cancer.
Radiopharmaceutical company AdvanCell has received $18 million from the Medical Research Future Fund…
The University of Queensland will play a key role in a national effort to revolutionize treatment for men with prostate cancer.
Radiopharmaceutical company AdvanCell has received $18 million from the Medical Research Future Fund…